Merck & Co., Inc. — Director's Dealing 2023

Oct 31, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2023-10-30

Reporting Person: Oosthuizen Johannes Jacobus (President, U.S. Market)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-10-30	Common Stock	M	915	$102.82	Acquired	20722.657	Direct
2023-10-30	Common Stock	F	451	$102.82	Disposed	20271.657	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-10-30	Restricted Stock Unit	$	M	915	Disposed	2023-10-30	Common Stock (915)	Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F3: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2021, 10/30/2022 and 10/30/2023.